Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vasculitis occurring during leflunomide therapy.

E A Holm1, E Balslev, G B Jemec

  • 1Department of Medicine, Division of Dermatology, Roskilde Hospital, Denmark. eholm@dadlnet.dk

Dermatology (Basel, Switzerland)
|November 10, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Suicidal ideation in patients with skin conditions: A multicentre European study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

A cross-sectional study on gender differences in body dysmorphic concerns in patients with skin conditions in relation to sociodemographic, clinical and psychological variables.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Quality of life measurement in urticaria: Position statement of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient-Oriented Outcomes and Urticaria and Angioedema.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Assessment of metabolic dysfunction-associated steatotic liver disease in patients with hidradenitis suppurativa: A cross-sectional study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: Results from a European multi-centre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Human leukocyte antigen system associations in Malassezia-related skin diseases.

Archives of dermatological research·2022
Same journal

Survey on Difficult to Treat Tinea: A Sub-Saharan Africa Snapshot.

Dermatology (Basel, Switzerland)·2026
Same journal

Mpox Outbreaks Beyond Historically Endemic Regions: A Clinical Review of Vaccination Strategies and Public Health Challenges.

Dermatology (Basel, Switzerland)·2026
Same journal

Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study.

Dermatology (Basel, Switzerland)·2026
Same journal

Descriptive Analysis of DRESS Reports from EudraVigilance and DRESS Cases from the RegiSCAR-project.

Dermatology (Basel, Switzerland)·2026
Same journal

The Role of the Vagus Nerve and Its Stimulation in Modulating Inflammatory Skin Diseases and Other Dermatologic Conditions: From Mechanisms to Therapeutics.

Dermatology (Basel, Switzerland)·2026
Same journal

Skin Barrier Dysfunction, Antimicrobial Peptide Alterations, and Microbiome Changes in Solid Cancer Patients Treated with Epidermal Growth Factor Receptor Inhibitors.

Dermatology (Basel, Switzerland)·2026
See all related articles

Leflunomide, used for rheumatoid arthritis, can cause vasculitis. This report details a patient experiencing this rare adverse effect, highlighting a potential risk of the immunosuppressive drug.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Leflunomide is a novel systemic treatment for rheumatoid arthritis.
  • It exhibits immunosuppressive and anti-inflammatory properties.

Observation:

  • A patient undergoing leflunomide therapy developed vasculitis.
  • This adverse event occurred during systemic treatment for rheumatoid arthritis.

Findings:

  • This case represents the first reported instance of vasculitis linked to leflunomide.
  • Vasculitis emerged as an adverse side effect of leflunomide treatment.

Implications:

  • Clinicians should be aware of the potential for leflunomide-induced vasculitis.
  • This finding necessitates further investigation into the safety profile of leflunomide.

Related Experiment Videos

  • Monitoring for vasculitis is crucial in patients treated with leflunomide.